Casdin Capital, LLC 13F Portfolio
| Entity | Category | QoQ AUM Change | AUM (13F) | # of Holdings | Performance Rank | Equities Trend |
|---|---|---|---|---|---|---|
CC Casdin Capital, LLC | Institutional Filer | ▼ 17.97% | $1.32B | 40 |
Current Portfolio Holdings
Showing all 40 reported positions by value
| # | Stock | Company Name | Sector | Shares Held | Market Value | % of Portfolio |
|---|---|---|---|---|---|---|
| 1 | RVMD | Revolution Medicines, Inc. | Healthcare | 2.6M | $250.6M | 18.98% |
| 2 | WGS | GeneDx Holdings Corp. | Healthcare | 3.0M | $193.1M | 14.62% |
| 3 | RLAY | Relay Therapeutics, Inc. | Healthcare | 14.4M | $143.5M | 10.86% |
| 4 | BLFS | BioLife Solutions, Inc. | Healthcare | 6.0M | $113.7M | 8.61% |
| 5 | LAB | Standard BioTools Inc. | Healthcare | 88.8M | $81.6M | 6.18% |
| 6 | ILMN | Illumina, Inc. | Healthcare | 530K | $65.3M | 4.95% |
| 7 | GPCR | Structure Therapeutics Inc. | Healthcare | 1.2M | $56.6M | 4.29% |
| 8 | TXG | 10x Genomics, Inc. | Healthcare | 2.3M | $48.3M | 3.66% |
| 9 | DNLI | Denali Therapeutics Inc. | Healthcare | 1.8M | $35.3M | 2.68% |
| 10 | BEAM | Beam Therapeutics Inc. | Healthcare | 1.4M | $32.2M | 2.44% |
| 11 | GH | Guardant Health, Inc. | Healthcare | 315K | $29.1M | 2.20% |
| 12 | NGNE | Neurogene Inc. | Healthcare | 1.4M | $28.6M | 2.17% |
| 13 | ALNY | Alnylam Pharmaceuticals, Inc. | Healthcare | 75K | $24.8M | 1.88% |
| 14 | MAZE | Maze Therapeutics, Inc. | Healthcare | 759K | $22.7M | 1.72% |
| 15 | SRRK | Scholar Rock Holding Corporation | Healthcare | 350K | $17.2M | 1.30% |
Showing 1 to 15 of 40 holdings